摘要 |
<p>The invention relates to novel guanidine derivatives, particularly to substituted guanidines of the formula <IMAGE> (I) having hypoglycaemic activity, for the oral treatment of hyperglycaemia in mammals, especially for the oral treatment of Diabetes mellitus.</p> |